https://www.fujifilm.com/sg/en/news/hq/5678
Is this a CYP sidestep or just increasing our number of future customers?
I've always thought that we need to get in at the ground floor of any MSC clinical trials, as it seems to be so hard to change anything later in the approvals process. If we're confident that we have the patents locked down, give researchers free access to the process, supply cells at cost price for research, then take a slice of the action once a product goes to market.
Stuart Robert's Pitt Street Report, page-35
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $48.78M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 145786 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |